Thu, June 24, 2021
Wed, June 23, 2021
Tue, June 22, 2021
Mon, June 21, 2021
Sun, June 20, 2021
Fri, June 18, 2021
Thu, June 17, 2021
Wed, June 16, 2021
Tue, June 15, 2021
Mon, June 14, 2021
Sun, June 13, 2021
Fri, June 11, 2021
Thu, June 10, 2021
Wed, June 9, 2021
Tue, June 8, 2021

Christopher Raymond Initiated (ACRS) at Buy and Held Target at $30 on, Jun 15th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-30-on-jun-15th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Christopher Raymond of Piper Sandler, Initiated "Aclaris Therapeutics, Inc." (ACRS) at Buy and Held Target at $30 on, Jun 15th, 2021.

Christopher has made no other calls on ACRS in the last 4 months.



There are 2 other peers that have a rating on ACRS. Out of the 2 peers that are also analyzing ACRS, 0 agree with Christopher's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Christopher


  • Raghuram Selvaraju of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $40 on, Wednesday, April 21st, 2021
  • Thomas Smith of "SVB Leerink" Maintained at Buy with Increased Target to $26 on, Thursday, March 4th, 2021

Publication Contributing Sources